Actualités Celyad Oncology SA - CYAD | Actions Euronext

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Celyad Oncology to Present at the 2024 SITC Annual Meeting

Regulatory News: Celyad Oncology (Euronext: CYAD) (the “Company”), today announces two poster presentations at the 39th Annual Meeting of the...

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the...

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a...

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the...

Celyad Oncology reports third quarter 2023 financial results and recent business highlights

Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which...

Celyad Oncology announces the termination of its American Depository Receipt program

MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Celyad Oncology SA (CYAD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CYAD Actualités

Celyad Oncology to Present at the 2024 SITC Annual Meeting

Celyad Oncology announces intention to terminate SEC reporting obligations

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad announces management change

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology reports third quarter 2023 financial results and recent business highlights

Celyad Oncology announces the termination of its American Depository Receipt program

Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Celyad Oncology SA (CYAD) Actualités

Celyad Oncology SA (CYAD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

CYAD Actualités

Celyad Oncology to Present at the 2024 SITC Annual Meeting

Celyad Oncology announces intention to terminate SEC reporting obligations

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad announces management change

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology reports third quarter 2023 financial results and recent business highlights

Celyad Oncology announces the termination of its American Depository Receipt program

Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application